GLENMARK.NS — Glenmark Pharmaceuticals Limited (Stock)

Price: $2240.9 · 1 day: -0.43% · 5 days: -1.90% · 1 month: -6.66% · YTD: +11.02%
As of 2026-10-16 08:18 UTC.

52-week range: $1792.6 – $2537.6 (currently at 60% of the range).

The brief

GLENMARK.NS is in a turning up, momentum soft. $2250 is the level overhead; $2231.91 the first support below.

4 of 6 technical checks lean bearish.

• Price vs 50-day: below
• Price vs 200-day: above
• 50d vs 200d avg: above
• MACD: bearish
• RSI momentum: 42
• 5-day tape: -1.9%

Key levels

Indicators

Next earnings: 2026-10-30.

Latest GLENMARK.NS news

• Global Vitiligo Treatment Market to Reach USD 2.97 Billion by 2034 at 5.8% CAGR as Rising Disease Prevalence, Growing Aesthetic Awareness, and Advances in Targeted Therapies Accelerate Market Growth, Reports Maximize Market Research — Maximize Market Research projects the global vitiligo treatment market will grow from USD 1.79 billion in 2025 to USD 2.97 billion by 2034, reflecting a 5.8% CAGR. Growth is driven by rising disease prevalence, increased (PR Newswire, 2026-09-23)
• Trump Sanctions on Cuba Strands Thousands Of Shipping Containers — U.S. sanctions imposed by the Trump administration have caused two major shipping lines, Hapag-Lloyd and CMA CGM, to halt deliveries to Cuba, stranding thousands of containers of food, medicine, and humanitarian aid acro (The New York Times, 2026-09-17)
• Council Post: Indian Pharma's Global Expansion Needs More Than Regulatory Readiness — Indian pharmaceutical companies and CDMOs are expanding globally, but regulatory readiness alone is insufficient for long-term growth, according to a Council Post by Aman Gupta of SPAG FINN Partners. India accounts for n (Forbes, 2026-09-11)
• Glenmark Pharmaceuticals and South Piedmont Community College Launch Aseptic Training Facility in Monroe, N.C. — Glenmark Pharmaceuticals and South Piedmont Community College have launched a new 21,000-square-foot Aseptic Training Facility in Monroe, North Carolina, supported by a $2.7 million investment from Glenmark. The facility (PR Newswire, 2026-09-10)
• Indian shares may open higher as traders trim Fed hike bets — Indian shares are expected to open higher on Friday, snapping a four-session losing streak, as traders reduced bets on a U.S. Federal Reserve rate hike in September. Fed Governor Christopher Waller signaled support for k (Reuters, 2026-09-04)
• Biosimilars Market worth $70.79 billion by 2036 - Exclusive Report by MarketsandMarkets™ — According to MarketsandMarkets™, the global biosimilars market is projected to grow from USD 37.39 billion in 2026 to USD 70.79 billion by 2036, representing a compound annual growth rate (CAGR) of 6.6%. North America is (PR Newswire, 2026-09-02)
• Connecticut Office of the Attorney General: If You Bought Certain Generic Prescription Drugs in the United States — Connecticut's Attorney General announced an additional $29.6 million settlement with Glenmark Pharmaceuticals in ongoing lawsuits alleging generic drug price-fixing between May 2009 and December 2019. Of this amount, $20 (PR Newswire, 2026-08-24)
• Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update — Shares of European and Asian generic-drug manufacturers declined after President Trump announced plans to impose tariffs on generic medicines starting in August 2028, with levies beginning at 100% for one year before ris (Morningstar, 2026-07-22)

Explore more

Interactive GLENMARK.NS chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs